Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 180 Records) |
Query Trace: DNA Damage and BRCA2[original query] |
---|
Ovarian High-grade Serous Carcinoma with Transitional-like (SET) Morphology: A Homologous Recombination-deficient Tumor. Human pathology 2023 9 . Emanuela D'Angelo, Iñigo Espinosa, Lara Felicioni, Fiamma Buttitta, Jaime Pr |
Clinical significance of DNA damage response mutations in stage I and stage IIIa NSCLC. Thoracic cancer 2023 9 . Haoran Zhang, Dongming Zhang, Jia Liu, Yuequan Shi, Xiaoyan Liu, Minjiang Chen, Wei Zhong, Jing Zhao, Yan Xu, Mengzhao Wa |
Next generation sequencing reveals a high prevalence of pathogenic mutations in homologous recombination DNA damage repair genes among patients with uterine sarcoma. Gynecologic oncology 2023 8 177 14-19. Dimitrios Nasioudis, Nawar A Latif, Emily M Ko, Lori Cory, Sarah H Kim, Lainie Martin, Fiona Simpkins, Robert Giunto |
Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficien cy in Pancreatic Acinar Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 8 JCO2300561. Diana Mandelker, Antonio Marra, Binbin Zheng-Lin, Pier Selenica, Juan Blanco-Heredia, Yingjie Zhu, Andrea Gazzo, Donna Wong, Zarina Yelskaya, Vikas Rai, Joshua Somar, Silvana Ostafi, Nikita Mehta, Ciyu Yang, Yirong Li, David N Brown, Edaise M da Silva, Xin Pei, Irina Linkov, Panieh Terraf, Maksym Misyura, Ozge Ceyhan-Birsoy, Marc Ladanyi, Michael Berger, Fresia Pareja, Zsofia Stadler, Kenneth Offit, Nadeem Riaz, Wungki Park, Joanne Chou, Marinela Capanu, Maria Koehler, Ezra Rosen, Eileen M O'Reilly, Jorge S Reis-Fil |
Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations. JCO precision oncology 2023 7 7 e2300095. Deborah B Doroshow, Peter H O'Donnell, Jean H Hoffman-Censits, Sumati V Gupta, Ulka Vaishampayan, Elisabeth I Heath, Philip Garcia, Qianqian Zhao, Menggang Yu, Matthew I Milowsky, Matthew D Gals |
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer. Human genomics 2023 7 17 (1): 66. Ning-Yuan Lee, Melissa Hum, Sabna Zihara, Lanying Wang, Matthew K Myint, Darren Wan-Teck Lim, Chee-Keong Toh, Anders Skanderup, Jens Samol, Min-Han Tan, Peter Ang, Soo-Chin Lee, Eng-Huat Tan, Gillianne G Y Lai, Daniel S W Tan, Yoon-Sim Yap, Ann S G L |
Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer. Journal of ovarian research 2023 7 16 (1): 141. A W Adamson, Y C Ding, L Steele, L A Leong, R Morgan, M T Wakabayashi, E S Han, T H Dellinger, P S Lin, A A Hakim, S Wilczynski, C D Warden, S Tao, V Bedell, M C Cristea, S L Neuhaus |
Analysis of Plasma Circulating Tumor DNA in Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Modified FOLFIRINOX: Clinical Relevance of DNA Damage Repair Gene Alteration Detection. Cancer research and treatment 2023 5 . Dong-Hoon Lim, Hyunseok Yoon, Kyu-Pyo Kim, Baek-Yeol Ryoo, Sang Soo Lee, Do Hyun Park, Tae Jun Song, Dae Wook Hwang, Jae Hoon Lee, Ki Byung Song, Song Cheol Kim, Seung-Mo Hong, Jaewon Hyung, Changhoon Y |
Germline DNA-Repair Genes and HOXB13 Mutations in Korean Men with Metastatic Prostate Cancer: Data from a Large Korean Cohort. The world journal of men's health 2023 4 . Sang Hun Song, Hak-Min Kim, Yu Jin Jung, Ha Rim Kook, Sungwon Jeon, Jong Bhak, Jin Hyuck Kim, Hakmin Lee, Jong Jin Oh, Sangchul Lee, Sung Kyu Hong, Seok-Soo By |
Differences in DNA damage repair gene mutations between left- and right-sided colorectal cancer. Cancer medicine 2023 4 . Wei Huang, Wenliang Li, Ning Xu, Hui Li, Zihan Zhang, Xiaolong Zhang, Tingting He, Jicheng Yao, Mian Xu, Qingqing He, Lijie Guo, Sen Zha |
Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer. Research square 2023 3 . Adamson Aaron W, Ding Yuan Chun, Steele Linda, Leong Lucile A, Morgan Robert, Wakabayashi Mark T, Han Ernest S, Dellinger Thanh H, Lin Paul S, Hakim Amy A, Wilczynski Sharon, Warden Charles D, Tao Shu, Bedell Victoria, Cristea Mihaela C, Neuhausen Susan |
Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study. Breast cancer research : BCR 2023 12 25 (1): 152. Han-Fang Cheng, Yi-Fang Tsai, Chun-Yu Liu, Chih-Yi Hsu, Pei-Ju Lien, Yen-Shu Lin, Ta-Chung Chao, Jiun-I Lai, Chin-Jung Feng, Yen-Jen Chen, Bo-Fang Chen, Jen-Hwey Chiu, Ling-Ming Tseng, Chi-Cheng Hua |
Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therapy. JCO precision oncology 2023 12 7 e2200648. Ida Micaily, Edik M Blais, Randi Carhart, Sophia Lam, Steven J Cohen, Shawna J Cannaday, David Halverson, Lynn M Matrisian, Patricia DeArbeloa, Dzung Thach, Emanuel Petricoin, Michael J Pishvaian, Harish Lavu, Charles J Yeo, Atrayee Basu Malli |
The enrichment of Fanconi anemia/homologous recombination pathway aberrations in ATM/ATR-mutated NSCLC was accompanied by unique molecular features and poor prognosis. Journal of translational medicine 2023 12 21 (1): 874. Wei Wei, Fangfang Shi, Yang Xu, Yang Jiao, Ying Zhang, Qiuxiang Ou, Xue Wu, Lingyi Yang, Jinhuo L |
Rate of Pathogenic Germline Variants in Patients With Lung Cancer. JCO precision oncology 2023 11 7 e2300190. Steven Sorscher, Jaclyn LoPiccolo, Brandie Heald, Elaine Chen, Sara L Bristow, Scott T Michalski, Sarah M Nielsen, Alix Lacoste, Emil Keyder, Hayan Lee, Robert L Nussbaum, Renato Martins, Edward D Espl |
The BRCA1 c.4096+1G>A Is a Founder Variant Which Originated in Ancient Times. International journal of molecular sciences 2023 11 24 (21): . Paolo Aretini, Silvano Presciuttini, Aldo Pastore, Alvaro Galli, Sara Panepinto, Mariella Tancredi, Matteo Ghilli, Chiara Guglielmi, Diletta Sidoti, Caterina Congregati, Maria Adelaide Cali |
Deleterious and ethnic-related BRCA1/2 mutations in tissue and blood of Egyptian colorectal cancer patients and its correlation with human papillomavirus. Clinical and experimental medicine 2023 10 . Amira Salah El-Din Youssef, Abdel Rahman N Zekri, Marwa Mohanad, Samah A Loutfy, Nasra F Abdel Fattah, Mostafa H Elberry, Asmaa A El Leithy, Ahmed El-Touny, Ahmed Samy Rabie, Mohamed Shalaby, Ayman Hanafy, Mai M Lotfy, Enas R El-Sisi, Gharieb S El-Sayyad, Auhood Nass |
Identification of pathogenic germline variants in a large Chinese lung cancer cohort by clinical sequencing. Molecular oncology 2023 10 . Zhe Yu, Zirui Zhang, Jun Liu, Xiaoying Wu, Xiaojun Fan, Jiaohui Pang, Hua Bao, Jiani Yin, Xue Wu, Yang Shao, Zhengcheng Liu, Fang L |
[Prostate cancer with BRCA2 pathogenic mutation: a clinicopathological analysis]. Zhonghua bing li xue za zhi = Chinese journal of pathology 2024 8 53 (8): 789-796. D H Wang, W L Yin, X Y Pan, M N Zhang, L Nie, X Q Chen, H Zeng, Q Zhou, N Ch |
The Role of hBRCA2 in the Repair of Spontaneous and UV DNA Damage in Saccharomyces cerevisiae. microPublication biology 2024 8 2024 . Sherrice Law, David Park, Hannah Park, Hannah Zhang, Damon Mey |
The Impact of Li Fraumeni and Germline Retinoblastoma Mutations on Leiomyosarcoma Initiation, Outcomes and Genetic Testing Recommendations. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 8 . Josephine K Dermawan, David H Abramson, Sarah Chiang, Martee L Hensley, William D Tap, Sujana Movva, Robert G Maki, Diana Mandelker, Cristina R Antones |
A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer. Cancer medicine 2024 8 13 (16): e70103. Jana Soukupova, Barbora Stastna, Madiha Kanwal, Jan Hojny, Petra Zemankova, Marianna Borecka, Leona Cerna, Marta Cerna, Monika Cerna, Vaclava Curtisova, Tatana Dolezalova, Petra Duskova, Lenka Foretova, Ondrej Havranek, Klara Horackova, Milena Hovhannisyan, Lucie Hruskova, Stepan Chvojka, Marketa Janatova, Maria Janikova, Sandra Jelinkova, Pavel Just, Marta Kalousova, Petra Kleiblova, Marcela Kosarova, Monika Koudova, Jan Kral, Michaela Krausova, Vera Krutilkova, Eva Machackova, Katerina Matejkova, Renata Michalovska, Petr Nehasil, Barbora Nemcova, Jan Novotny, Matous Palek, Pavel Pesek, Marketa Safarikova, Ondrej Scheinost, Drahomira Springer, Lenka Stolarova, Viktor Stranecky, Ivan Subrt, Spiros Tavandzis, Eva Tureckova, Kamila Vesela, Zdenka Vlckova, Michal Vocka, Tomas Zima, Libor Macurek, Zdenek Kleibl, |
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients. European journal of cancer (Oxford, England : 1990) 2024 7 208 114226. Giulia Orsi, Catia Carconi, Paola Ghiorzo, Paola Carrera, Lorenza Pastorino, Silvia Presi, Marta Chiaravalli, Elena Barbieri, Guido Giordano, Stefania Sciallero, Alberto Puccini, Lisa Salvatore, Laura Cortesi, Marina Macchini, Maria Iole Natalicchio, Eleonora Allavena, Chiara Pirrone, Livia Archibugi, Bruna Dalmasso, William Bruno, Giampaolo Tortora, Matteo Landriscina, Gabriele Capurso, Stefano Cascinu, Massimo Falconi, Michele Re |
Prevalence of pathogenic or likely pathogenic germline variants in cancer predisposition genes among selected patients with lung adenocarcinoma: The GERMLUNG study. Lung cancer (Amsterdam, Netherlands) 2024 6 194 107864. Oscar Arrieta, Enrique Caballé-Pérez, Norma Hernández-Pedro, Eunice Romero-Nuñez, José Lucio-Lozada, Cesar Castillo-Ruiz, Karla Acevedo-Castillo, Rosa María Álvarez-Gómez, Carolina Molina-Garay, Marco Jiménez-Olivares, Karol Carrillo-Sánchez, Elvia Cristina Mendoza-Caamal, Andrés F Cardona, Jordi Remon, Carmen Alaez-Vers |
Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status. Breast cancer (Tokyo, Japan) 2024 6 . Melinda L Telli, Jennifer K Litton, J Thaddeus Beck, Jason M Jones, Jay Andersen, Lida A Mina, Raymond Brig, Michael Danso, Yuan Yuan, William F Symmans, Julia F Hopkins, Lee A Albacker, Antonello Abbattista, Kay Noonan, Marielena Mata, A Douglas Laird, Joanne L Bl |
Identification of RAD17 as a candidate cancer predisposition gene in families with histories of pancreatic and breast cancers. BMC cancer 2024 6 24 (1): 723. Sofie Joris, Philippe Giron, Catharina Olsen, Sara Seneca, Alexander Gheldof, Shula Staessens, Rajendra Bahadur Shahi, Sylvia De Brakeleer, Erik Teugels, Jacques De Grève, Frederik J H |
Mutation characteristics of cancer susceptibility genes in Chinese ovarian cancer patients. Frontiers in oncology 2024 5 14 1395818. Jie Wang, Kaiyu Fu, Mengpei Zhang, Lunggang Liang, Meng Ni, Hai-Xi Sun, Rutie Yin, Meifang Ta |
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases. medRxiv : the preprint server for health sciences 2024 5 . Jonathan Mitchell, Niedzica Camacho, Patrick Shea, Konrad H Stopsack, Vijai Joseph, Oliver Burren, Ryan Dhindsa, Abhishek Nag, Jacob E Berchuck, Amanda O'Neill, Ali Abbasi, Anthony W Zoghbi, Jesus Alegre-Díaz, Pablo Kuri-Morales, Jaime Berumen, Roberto Tapia-Conyer, Jonathan Emberson, Jason M Torres, Rory Collins, Quanli Wang, David Goldstein, Athena Matakidou, Carolina Haefliger, Lauren Anderson-Dring, Ruth March, Vaidehi Jobanputra, Brian Dougherty, Keren Carss, Slavé Petrovski, Philip W Kantoff, Kenneth Offit, Lorelei A Mucci, Mark Pomerantz, Margarete A Fab |
Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways. The Prostate 2024 1 . Jason A White, Ernest T Kaninjing, Kayode A Adeniji, Paul Jibrin, John O Obafunwa, Chidiebere N Ogo, Faruk Mohammed, Ademola Popoola, Omolara A Fatiregun, Olabode P Oluwole, Roland J Thorpe, Balasubramanyam Karanam, Isra Elhussin, Stefan Ambs, Wei Tang, Melissa Davis, Paz Polak, Moray J Campbell, Kathryn R Brignole, Solomon O Rotimi, Windy Dean-Colomb, Folake T Odedina, Clayton Yat |
Germline DNA Damage Response Gene Mutations in Localized Prostate Cancer. Medicina (Kaunas, Lithuania) 2024 1 60 (1): . Tomas Januskevicius, Ieva Vaicekauskaite, Rasa Sabaliauskaite, Augustinas Matulevicius, Alvydas Vezelis, Albertas Ulys, Sonata Jarmalaite, Feliksas Jankevici |
- Page last reviewed:Feb 1, 2024
- Content source: